Homie Razavi
Biographic Data
| ID | 5562608 |
|---|---|
| NAME | Homie Razavi |
| GIVEN NAMES | Homie |
| FAMILY NAME | Razavi |
| SIGNATURE | RAZAVI H |
| AFFILIATIONS | CDA Foundation Lafayette CO USA |
| ORCID | 0000-0002-2658-6930 |
| VERIFIED | Yes |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 10 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2012 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
The investment case for hepatitis B and C in South Africa
Even though WHO has approved global goals for hepatitis elimination, most countries have yet to establish programs for hepatitis B and C, which account for 320 million infections and over a million deaths annually. One reason for this slow response is the paucity of robust, compelling analyses showing that national HBV/HCV programs could have a significant impact on these epidemics and save lives in a cost-effective, affordable manner. In this co…
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013
Global, regional, and national disability-adjusted life years (Dalys) for 306 diseases and injuries and healthy life expectancy (Hale) for 188 countries, 1990–2013
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010
Disability-adjusted life years (Dalys) for 291 diseases and injuries in 21 regions, 1990–2010
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010
No prominent works on this page.
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010
Disability-adjusted life years (Dalys) for 291 diseases and injuries in 21 regions, 1990–2010
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990–2013
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013
Global, regional, and national disability-adjusted life years (Dalys) for 306 diseases and injuries and healthy life expectancy (Hale) for 188 countries, 1990–2013
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
The investment case for hepatitis B and C in South Africa
Even though WHO has approved global goals for hepatitis elimination, most countries have yet to establish programs for hepatitis B and C, which account for 320 million infections and over a million deaths annually. One reason for this slow response is the paucity of robust, compelling analyses showing that national HBV/HCV programs could have a significant impact on these epidemics and save lives in a cost-effective, affordable manner. In this co…
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
Medicine (10 works) · Environmental health (9 works) · Demography (6 works) · Population (6 works) · Disease burden (4 works) · Health disparities and outcomes (4 works) · Disease (3 works) · Epidemiology (3 works) · Gerontology (3 works) · Global health (3 works)